Gene Expression Profiling Specifies Chemokine, Mitochondrial and Lipid Metabolism Signatures in Leprosy

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Guerreiro, Luana Tatiana Albuquerque ^a   Robottom Ferreira, Anna Beatriz ^a   Ribeiro Alves, Marcelo ^a,b   Toledo Pinto, Thiago Gomes ^a   Rosa Brito, Tiana ^a   Rosa, Patrícia Sammarco ^c   Sandoval, Felipe Galvan ^d   Jardim, Márcia Rodrigues ^a   Antunes, Sérgio Gomes ^a   Shannon, Edward J ^d   Sarno, Euzenir Nunes ^a   Pessolani, Maria Cristina Vidal ^a   Williams, Diana Lynn ^d   Moraes, Milton Ozório ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

^d LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTOME;

ARTICLE; BACTERIAL STRAIN; CCL2 GENE; CCL3 GENE; CCL4 GENE; CLASSIFICATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IL8 GENE; LDLR GENE; LEPROSY; LIPID METABOLISM; MITOCHONDRIAL RESPIRATION; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NERVE BIOPSY; NONHUMAN; PERIPHERAL NEUROPATHY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; SOD2 GENE; UBIQUITINATION; UPREGULATION; CELL CULTURE; CLUSTER ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MITOCHONDRION; PERIPHERAL NERVE;

MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM LEPRAE;

CELLS, CULTURED; CHEMOKINES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; LEPROSY; LIPID METABOLISM; MALE; MITOCHONDRIA; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIPHERAL NERVES; SCHWANN CELLS; TRANSCRIPTOME;

EID: 84879060989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064748     Document Type: Article

References (68)

1. Suzuki K, Fukutomi Y, Matsuoka M, Torii K, Hayashi H, et al. (1993) Differential production of interleukin 1 (IL-1), IL-6, tumor necrosis factor, and IL-1 receptor antagonist by human monocytes stimulated with Mycobacterium leprae and M. bovis BCG. Int J Lepr 61: 609-618.
2. Murray RA, Siddiqui MR, Mendillo M, Krahenbuhl J, Kaplan G, (2007) Mycobacterium leprae inhibits dendritic cell activation and maturation. J Immunol 178: 338-344.
3. Sinsimer D, Fallows D, Peixoto B, Krahenbuhl J, Kaplan G, et al. (2010) Mycobacterium leprae actively modulates the cytokine response in naive human monocytes. Infect Immun 78: 293-300.
4. Montoya D, Cruz D, Teles R, Lee DJ, Ochoa MT, et al. (2009) Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6: 343-353.
5. Schuring RP, Hamann L, Faber WR, Pahan D, Richardus JH, et al. (2009) Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J Infect Dis 199: 1816-1819.
6. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, et al. (2009) Genomewide association study of leprosy. N Engl J Med 361: 2609-2618.
7. Alter A, de Leseleuc L, Van Thuc N, Thai VH, Huong NT, et al. (2010) Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum Genet 127: 337-348.
8. Sapkota BR, Macdonald M, Berrington WR, Misch EA, Ranjit C, et al. (2010) Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. Hum Immunol 71: 992-998.
9. Wong SH, Gochhait S, Malhotra D, Pettersson FH, Teo YY, et al. (2010a) Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog 6: e1000979.
10. Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO, (2011a) Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol 6: 533-549.
11. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
12. Wong SH, Hill AV, Vannberg FO, (2010b) Genomewide association study of leprosy. N Engl J Med 362: 1446-7 author reply 1447-1448.
13. Grant AV, Alter A, Huong NT, Orlova M, Van Thuc N, et al. (2012) Crohn's Disease susceptibility genes are associated with leprosy in the Vietnamese population. J Infect Dis 206: 1763-1767.
14. Mira MT, Alcais A, Nguyen VT, Nguyen NB, Pham XK, et al. (2004) Susceptibility to leprosy is associated with PARK and PACRG. Nature 427: 636-640.
15. Alcais A, Alter A, Antoni G, Orlova M, Nguyen VT, et al. (2007) Stepwise replication identifies a low-producing lymphotoxin-a allele as a major risk factor for early-onset leprosy. Nat Genet 39: 517-522.
16. Cardoso CC, Pereira AC, Brito-de-Souza VN, Dias-Baptista IM, Maniero VC, et al. (2010) IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians. Hum Genet 128: 481-490.
17. Hagge DA, Saunders BM, Ebenezer GJ, Ray NA, Marks VT, et al. (2009) Lymphotoxin-alpha and TNF have essential but independent roles in the evolution of the granulomatous response in experimental leprosy. Am J Pathol 174: 1379-1389.
18. Cardoso CC, Pereira AC, Brito-de-Souza VN, Duraes SM, Ribeiro-Alves M, et al. (2011b) TNF -308G>A single nucleotide polymorphism is associated with leprosy among Brazilians: a genetic epidemiology assessment, meta-analysis, and functional study. J Infect Dis 204: 1256-1263.
19. Pereira AC, Brito-de-Souza VN, Cardoso CC, Dias-Baptista IM, Parelli FP, et al. (2009) Genetic, epidemiological and biological analysis of interleukin-10 promoter single nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun 10: 174-180.
20. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, et al. (2004) Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 5: 46-57.
21. Miller EN, Jamieson SE, Joberty C, Fakiola M, Hudson D, et al. (2004) Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun 5: 63-67.
22. Tobin DM, Vary JC Jr, Ray JP, Walsh GS, Dunstan SJ, et al. (2010) The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140: 717-730.
23. Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, et al. (2012) Host genotype specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148: 434-446.
24. Jardim MR, Antunes SL, Simons B, Wildenbeest JG, Nery JAC, et al. (2005) Role of PGL-I antibody detection in the diagnosis of pure neural leprosy. Lepr Rev 76: 232-240.
25. Antunes SL, Chimelli L, Jardim MR, Vital RT, Nery JA, et al. (2012) Histopathological examination of nerve samples from pure neural leprosy patients: obtaining maximum information to improve diagnostic efficiency. Mem Inst Oswaldo Cruz 107: 246-253.
26. Menicucci LA, Miranda A, Antunes SL, Jardim MR, da Costa Nery JA, et al. (2005) Microscopic leprosy skin lesions in primary neuritic leprosy. J Am Acad Dermatol 52: 648-652.
27. Martinez AN, Britto CF, Nery JA, Sampaio EP, Jardim MR, et al. (2006) Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy. J Clin Microbiol 44: 3154-3159.
28. Martinez AN, Lahiri R, Pittman TL, Scollard D, Truman R, et al. (2009) Molecular determination of Mycobacterium leprae viability by use of real-time PCR. J Clin Microbiol 47: 2124-2130.
29. Truman RW, Krahenbuhl JL, (2001) Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis 69: 1-12.
30. Lahiri R, Randhawa B, Krahenbuhl J, (2005) Application of a viability staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad. J Med Microbiol 54: 235-242.
31. Hagge DA, Oby Robinson S, Scollard D, McCormick G, Williams DL, (2002) A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions. J Infect Dis 186: 1283-1296.
32. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
33. Smyth GK, Michaud J, Scott HS, (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075.
34. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57: 289-300.
35. R Development Core Team (2009) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria Available: http://cran.r-project.org.
36. Smyth GK, (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat App Gen Mol Biol doi:10.2202/1544-6115.1027.
37. Huang W, Sherman BT, Lempicki RA, (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Prot 4: 44-57.
38. Ritz C, Spiess AN, (2008) qpcR: an R package for sigmoidal model selection in quantitative real-time polymerase chain reaction analysis. Bioinformatics 1: 1549-1551.
39. Vandesompele J, Preter KD, Pattyn F, Poppe B, Roy NV, et al. (2003) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol doi:10.1186/gb-2002-3-7-research0034.
40. Andersen CL, Jensen JL, Ørntoft TF, (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
41. Basso D, Pesarin F, Salmaso L, Solari A (2009) Nonparametric One-Way ANOVA. In: Bickel P et al. Editors. Permutation Tests for Stochastic Ordering and ANOVA: Theory and Applications with R: Springer, New York. pp. 133-172.
42. Savage RS, Ghahramani Z, Griffin JE, de la Cruz BJ, Wild DL, (2010) Discovering transcriptional modules by Bayesian data integration. Bioinformatics 26: i158-i167.
43. Martinez AN, Ribeiro-Alves M, Sarno EM, Moraes MO, (2011) Evaluation of qPCR-Based Assays for Leprosy Diagnosis Directly in Clinical Specimens. PLoS Negl Trop Dis 5: e1354.
44. Prevention Trial Group (1996) Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348: 17-24.
45. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, et al. (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19: 338-381.
46. Merle CS, Cunha SS, Rodrigues LC, (2010) BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control. Expert Rev Vaccines 9: 209-222.
47. Paul S, Laochumroonvorapong P, Kaplan G, (1996) Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J Infect Dis 174: 105-112.
48. Oliveira MM, Charlab R, Pessolani MCV, (2001) Mycobacterium bovis BCG but not Mycobacterium leprae Induces TNF-a Secretion in Human Monocytic THP-1 cells. Mem Inst Oswaldo Cruz 96: 973-978.
49. Theus SA, Cave MD, Eisenach KD, (2004) Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect Immun 72: 1169-1173.
50. Mattos KA, D'Avila H, Rodrigues LS, Oliveira VG, Sarno EN, et al. (2010) Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J Leukoc Biol 87: 371-384.
51. Mattos KA, Oliveira VG, D'Avila H, Rodrigues LS, Pinheiro RO, et al. (2011) TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence. J Immunol 187: 2548-2558.
52. Sun Y, Liu H, Yu G, Chen X, Liu H, et al. (2011) Gene expression analysis of leprosy by using a multiplex branched DNA assay. Exp Dermatol 20: 520-522.
53. Peyron P, Bordier C, N'Diaye EN, Maridonneau-Parini I, (2000) Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. J Immunol 165: 5186-5191.
54. Virchow R (1863) Die krankhaften Geschwu lste, August Hirschwald, Berlin, 208 pp.
55. Job CK, (1970) Mycobacterium leprae in nerve lesions in lepromatous leprosy: an electron microscopic study. Arch Pathol 89: 195-207.
56. Pandey AK, Sassetti CM, (2008) Mycobacterial persistence requires the utilization of host cholesterol. P Natl Acad Sci U S A 105: 4376-4380.
57. Griffin JE, Pandey AK, Gilmore SA, Mizrahi V, McKinney JD, et al. (2012) Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol 19: 218-227.
58. Al-Mubarak R, Vander Heiden J, Broeckling CD, Balagon M, Brennan PJ, et al. (2011) Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. PLoS Negl Trop Dis 5: e1303.
59. Hasan Z, Ashraf M, Tayyebi A, Hussain R, (2006) M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression. BMC Microbiol 6: 78.
60. Berger AK, Cortese GP, Amodeo KD, Weihofen A, Letai A, et al. (2009) Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum Mol Genet 18: 4317-4328.
61. Garg N, Popov VL, Papaconstantinou J, (2003) Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim Biophys Acta 11638: 106-120.
62. Geluk A, Bobosha K, van der Ploeg-van Schip JJ, Spencer JS, Banu S, et al. (2012) New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy. J Immunol 188: 4782-4791.
63. Teles RM, Graeber TG, Krutzik SR, Montoya D, Schenk M, et al. (2013) Type I Interferon Suppresses Type II Interferon-Triggered Human Anti-Mycobacterial Responses. Science 339: 1448-1453.
64. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
65. Maertzdorf J, Ota M, Repsilber D, Mollenkopf HJ, Weiner J, et al. (2011) Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One 6: e26938.
66. Bloom CI, Graham CM, Berry MP, Wilkinson KA, Oni T, et al. (2012) Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PloS One 7: e4691.
67. Ottenhoff TH, Dass RH, Yang N, Zhang MM, Wong HE, et al. (2012) Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One 7: e45839.
68. Wu K, Dong D, Fang H, Levillain F, Jin W, et al. (2012) An interferon-related signature in the transcriptional core response of human macrophages to Mycobacterium tuberculosis infection. PLoS One 7: e38367.